Lucas Potter

Protiva Das, Sovon Chakraborty, Sidhant Narula et al.

The rapid advancement of Large Language Models (LLMs) in biological research has significantly lowered the barrier to accessing complex bioinformatics knowledge, ex perimental design strategies, and analytical workflows. While these capabilities accelerate innovation, they also introduce serious dual-use risks, as Bio-LLMs can be exploited to generate harmful biological insights under the guise of legitimate research queries. Existing safeguards, such as static prompt filtering and policy-based restrictions, are insufficient when LLMs are embedded within dynamic biological workflows and application-layer systems. In this paper, we present BioShield, a context-aware application-level firewall designed to secure Bio LLMs against dual-use attacks. At the core of BioShield is a domain-specific prompt scanner that performs contextual risk analysis of incoming queries. The scanner leverages a harmful scoring mechanism tailored to biological dual-use threat cat egories to identify prompts that attempt to conceal malicious intent within seemingly benign research requests. Queries ex ceeding a predefined risk threshold are blocked before reaching the model, effectively preventing unsafe knowledge generation at the source. In addition to pre-generation protection, BioShield deploys a post-generation output verification module that inspects model responses for actionable or weaponizable biological content. If an unsafe response is detected, the system triggers controlled regeneration under strengthened safety constraints. By combining contextual prompt scanning with response-level validation, BioShield provides a layered defense framework specifically designed for bio-domain LLM deployments. Our framework advances cyberbiosecurity by formalizing dual-use threat detection in Bio-LLMs and proposing a structured mitigation strategy for secure, responsible AI driven biological research.

Austin James, Xavier-Lewis Palmer, Lucas Potter et al.

Automated insulin delivery (AID) and artificial pancreas systems increasingly serve as safety-critical cyber-physical technologies in clinical care, integrating sensors, algorithms, software, and insulin-delivery hardware to automate a life-sustaining therapy. While regulated commercial systems are supported by formal approval pathways, manufacturer governance, and post-market surveillance, clinicians are also encountering patients who rely on do-it-yourself (DIY) artificial pancreas systems that operate outside conventional regulatory and institutional control structures. This paper examines how routine clinical handling practices intersect with cyberbiosecurity risk across both regulated and DIY AID systems. When insulin delivery systems are fundamentally reconfigured into a bespoke AID system, with the patient-user becoming the primary threat vector by assuming manufacturer-level roles without mandated governance, the entire ecosystem of stakeholders is placed in legal and clinical uncertainty.

Lucas Potter, Orlando Ayala, Xavier-Lewis Palmer

Biodefense is the discipline of ensuring biosecurity with respect to select groups of organisms and limiting their spread. This field has increasingly been challenged by novel threats from nature that have been weaponized such as SARS, Anthrax, and similar pathogens, but has emerged victorious through collaboration of national and world health groups. However, it may come under additional stress in the 21st century as the field intersects with the cyberworld -- a world where governments have already been struggling to keep up with cyber attacks from small to state-level actors as cyberthreats have been relied on to level the playing field in international disputes. Disruptions to military logistics and economies through cyberattacks have been able to be done at a mere fraction of economic and moral costs through conventional military means, making it an increasingly tempting means of disruption. In the field of biocybersecurity (BCS), the strengths within biotechnology and cybersecurity merge, along with many of their vulnerabilities, and this could spell increased trouble for biodefense, as novel threats can be synthesized and disseminated in ways that fuse the routes of attacks seen in biosecurity and cybersecurity. Herein, we offer an exploration of how threats in the domain of biocybersecurity may emerge through less foreseen routes as it might be an attractive auxiliary to conventional war. This is done through an analysis of potential payload and delivery methods to develop notional threat vectorizations. We conclude with several paradigms through which to view BCS-based threats.

Lucas Potter, Xavier-Lewis Palmer

Within the field of biocybersecurity, it is important to understand what vulnerabilities may be uncovered in the processing of biologics as well as how they can be safeguarded as they intersect with cyber and cyberphysical systems, as noted by the Peccoud Lab, to ensure not only product and brand integrity, but protect those served. Recent findings have revealed that biological systems can be used to compromise computer systems and vice versa. While regular and sophisticated attacks are still years away, time is of the essence to better understand ways to deepen critique and grasp intersectional vulnerabilities within bioprocessing as processes involved become increasingly digitally accessible. Wargames have been shown to be successful with-in improving group dynamics in response to anticipated cyber threats, and they can be used towards addressing possible threats within biocybersecurity. Within this paper, we discuss the growing prominence of biocybersecurity, the importance of biocybersecurity to bioprocessing , with respect to domestic and international contexts, and reasons for emphasizing the biological component in the face of explosive growth in biotechnology and thus separating the terms biocybersecurity and cyberbiosecurity. Additionally, a discussion and manual is provided for a simulation towards organizational learning to sense and shore up vulnerabilities that may emerge within an organization's bioprocessing pipeline